We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

By LabMedica International staff writers
Posted on 25 Jul 2025

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. More...

However, obtaining PRP traditionally requires expensive centrifugation techniques, may prematurely activate platelets, and often reduce their therapeutic effectiveness. These methods also involve complex equipment and handling that limit their use in low-resource or point-of-care settings. To overcome these challenges, researchers have developed a novel method that separates PRP directly from blood without requiring centrifugation. The new approach yields high-quality, minimally activated platelets, offering a cost-effective and portable alternative to existing methods.

This solution, developed at the University of the Basque Country (Leioa, Spain), is a disposable, low-cost device based on gravity sedimentation, a process where denser particles settle under gravity. Unlike traditional centrifuge-based equipment, the system is made from laser-cut acrylic sheets and special adhesives, making it affordable and easy to manufacture. This innovation is the result of over a decade of research into Lab-on-a-Chip technologies—compact systems that replicate laboratory functions on a single microdevice. During their studies, the team observed that plasma separated in these devices was rich in low-activated platelets, prompting a redesign for therapeutic purposes. The device can extract about 300 microliters of PRP from 1 milliliter of blood in 40 minutes and can be scaled for different blood volumes.

The system was tested and validated through performance metrics, including platelet activation levels and blood component separation. Compared to traditional methods, platelet activation was significantly reduced to 8.2% from 31%, while maintaining the mean platelet volume crucial for PRP efficacy. It also eliminated 98% of red blood cells and 96% of white blood cells. The findings, published in Lab on a Chip, demonstrate the device’s potential for use in personalized treatments, resource-limited clinics, and home healthcare.

Related Links:
University of the Basque Country


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Portable POCT Blood Gas Analyzer
BD100
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.